Overview on ECRC funded projects and research groups
ECRC-funded research groups
|
Cardiovascular diseases and metabolism |
|
|
Prof. Friedrich Luft
|
Nephrology/ Hypertension |
|
Prof. Maik Gollasch
|
Smooth Muscle Cell Electrophysiology and Ion Channels |
|
Prof. Ralph Kettritz
|
Nephrology and Inflammatory Vascular Diseases |
|
Prof. Dominik Müller / Dr. Ralf Dechend
|
Hypertension-caused End-Organ Damage |
|
Prof. Jeanette Schulz-Menger
|
Cardiac MRI |
|
Prof. Silke R. Sperling
|
Cardiovascular Genetics |
|
Prof. Joachim Spranger
|
|
|
Prof. Simone Spuler
|
Myology |
|
Cancer |
|
|
Prof. Bernd Dörken
|
Haematology / Tumorimmunology |
|
Prof. Peter Schlag
|
Surgical Oncology |
ECRC-funded Project Groups
|
Project group leader |
Project title |
|
Dr. Christian Geier Clinic for Cardiology |
Genetic mechanisms of heart disease |
|
Dr. Torsten Kai Roepke
Clinic for Cardiology and Angiology |
The Role of KCNEs in mammalian physiology |
|
Dr. Il-Kang Na
Clinic for Haematology and Oncology |
|
|
Dr. Jens Fielitz
Clinic for Cardiology |
|
|
Dr. Christian Fischer
Hepatology and Gasteroenterology |
Directors from the brain gut axis: the functional role of Slit and Robo axonal guidance factors for vascularization and progression of neuroendocrine tumors |
|
Dr. Klemens Raile
Clinic for Pediatrics |
Human gene variations causing beta-cell dysfunction |
|
Dr. Sonia Waiczies
MDC |
Magnetic Resonance Imaging in Immunology |
Collaborative ECRC projects (since 2008)
|
Project leader |
Project title |
| Brenda Gerull, Arnd Heuser, Ludwig Thierfelder, MDC | Molecular characterization of disease mechanisms involved in arrhythmogenic right ventricular cardiomyopathy (ARVC) |
| Ralph Kettritz, Charité Norbert Hübner, Proteomics Facility, MDC Jens von Kries, FMP |
Novel mechanisms of ANCA-induced vasculitis and neutrophil activation |
| Ferdinand le Noble, MDC Ivo Buschmann, Charité |
Arteriogenesis: from molecular concepts to therapeutic interventions |
| Gary Lewin, Alistar Garratt, Carmen Birchmeier, MDC Joerg Westermann, Charité |
Clinical evaluation and discovery of novel analgesics to treat inflammatory and neuropathic pain |
| Dominik Müller, MDC / ECRC Ralf Dechend, Charité / Helios Kliniken GmbH |
The renin-angiotensin system and target organ damage |
| Clemens Schmitt, Bernd Doerken, Stephan Mathas, Charité Martin Janz, Frank Rosenbauer, Claus Scheidereit, MDC Jens von Kries, FMP |
Targeting Malignant Plasticity |
| Friedemann Paul, Charité / ECRC | Mechanism of action of Epigallocatechin-Gallate (EGCG) in relapsing-remitting Multiple Sclerosis |

